Favorable Press Coverage Somewhat Unlikely to Affect Fluidigm (FLDM) Share Price

Media headlines about Fluidigm (NASDAQ:FLDM) have trended positive this week, Accern reports. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Fluidigm earned a news impact score of 0.27 on Accern’s scale. Accern also gave news stories about the medical research company an impact score of 44.8576539507392 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Shares of Fluidigm stock traded up $0.14 during midday trading on Thursday, reaching $6.06. The company had a trading volume of 114,535 shares, compared to its average volume of 213,682. The company has a debt-to-equity ratio of 6.31, a current ratio of 2.83 and a quick ratio of 2.38. The firm has a market cap of $218.90, a P/E ratio of -5.09 and a beta of 2.99. Fluidigm has a 1-year low of $2.52 and a 1-year high of $8.38.

How to Become a New Pot Stock Millionaire

Fluidigm (NASDAQ:FLDM) last issued its quarterly earnings results on Thursday, February 8th. The medical research company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.02). Fluidigm had a negative net margin of 59.38% and a negative return on equity of 118.56%. The company had revenue of $27.75 million during the quarter, compared to analyst estimates of $27.14 million. During the same period in the prior year, the business earned ($0.32) EPS. The business’s revenue for the quarter was up 10.6% on a year-over-year basis. sell-side analysts expect that Fluidigm will post -0.93 EPS for the current year.

Several analysts have recently weighed in on FLDM shares. BidaskClub raised shares of Fluidigm from a “buy” rating to a “strong-buy” rating in a report on Tuesday, February 13th. Piper Jaffray reaffirmed a “hold” rating and set a $6.10 price objective on shares of Fluidigm in a report on Thursday, February 8th. Finally, ValuEngine lowered shares of Fluidigm from a “sell” rating to a “strong sell” rating in a report on Friday, February 2nd.

In other Fluidigm news, insider Levin Capital Strategies, L.P. acquired 6,871 shares of Fluidigm stock in a transaction on Tuesday, January 23rd. The shares were purchased at an average cost of $6.57 per share, with a total value of $45,142.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders acquired 723,607 shares of company stock worth $4,498,707. Insiders own 4.70% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Favorable Press Coverage Somewhat Unlikely to Affect Fluidigm (FLDM) Share Price” was originally posted by BBNS and is the sole property of of BBNS. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://baseballnewssource.com/2018/04/05/fluidigm-fldm-earning-positive-news-coverage-study-shows/2028859.html.

Fluidigm Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Almora Jr. and Baez Could Become Cubs new One-Two Tandem
Almora Jr. and Baez Could Become Cubs new One-Two Tandem
Red Sox Tie Record for Best Start After 17 Games
Red Sox Tie Record for Best Start After 17 Games
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Rick Porcello’s Strong Start Gives Boost to Red Sox
Rick Porcello’s Strong Start Gives Boost to Red Sox
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Xander Bogaerts Goes on Red Sox DL
Xander Bogaerts Goes on Red Sox DL


Leave a Reply

 
© 2006-2018 BBNS.